Clinical efficacy, speed of improvement and safety of apremilast for the treatment of adult Psoriasis during COVID-19 pandemic.

Melis, Daniele; Mugheddu, Cristina; Sanna, Silvia; Atzori, Laura; Rongioletti, Franco

Melis, Daniele; Mugheddu, Cristina; Sanna, Silvia; Atzori, Laura; Rongioletti, Franco.

Afiliación

Melis D; Dermatology Clinic, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Mugheddu C; Dermatology Clinic, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Sanna S; Dermatology Clinic, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Atzori L; Dermatology Clinic, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Rongioletti F; Dermatology Clinic, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Dermatol Ther ; 33(4): e13722, 2020 Jul.

Article en En | MEDLINE | ID: mdl-32475036

Asunto(s)

Antiinflamatorios no Esteroideos/uso terapéutico; Infecciones por Coronavirus/epidemiología; Neumonía Viral/epidemiología; Psoriasis/tratamiento farmacológico; Talidomida/análogos & derivados; Adulto; Anciano; Anciano de 80 o más Años; Betacoronavirus; COVID-19; Femenino; Humanos; Masculino; Persona de Mediana Edad; Pandemias; SARS-CoV-2; Talidomida/uso terapéutico

Palabras clave

COVID-19; apremilast; efficacy; psoriasis; safety

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neumonía Viral / Psoriasis / Talidomida / Antiinflamatorios no Esteroideos / Infecciones por Coronavirus Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Dermatol Ther Asunto de la revista: DERMATOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google